Xcout IntelSign inSubscribe

Cerapedics

Medical DevicesUnited States

Cerapedics Inc. is headquartered in Westminster, Colorado, United States, and develops orthopedic biologics and bone graft products.

Subscribe to see Cerapedics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

Cerapedics at a glance

Cerapedics is a medical devices company headquartered in United States. Its most recent funding round raised $25M in February 2022. Xcout tracks 13 named people at Cerapedics, including Valeska Schroeder (Chief Executive Officer).

Industry
Medical Devices
Headquarters
United States

Cerapedics leadership

  • Valeska SchroederChief Executive Officer
  • Mani GopalChief Operating Officer
  • Martyn WebsterChief Financial Officer
  • Jeffrey G. MarxChief Scientific Officer
  • Nathan PhilippChief Commercial Officer
  • Kimberly BurkeGeneral Counsel

7 more named people on record for Cerapedics, with roles, board committees and tenure — see the full roster →

Cerapedics funding rounds

The 4 most recent:

DateRoundAmountInvestors
—$25M—
—$22M1 named
SEC Form D filing$11M—
SEC Form D filing$4M—

Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →

Investors

Cerapedics competitors

A few of Cerapedics's closest competitors — see the full list of competitors and alternatives →

MiMedx Group, IncMDXG · Medical DevicesMarietta, United States
64% matchPublic

MiMedx Group, Inc. specializes in creating and supplying allografts derived from placental tissue, serving a diverse range of medical fields. The company employs its unique, patented PURION process to treat human placental tissues, a method crucial for manufacturing allografts that preserve the natural biological characteristics and essential regulatory proteins of the original tissue. This exclusive and patented processing technique incorporates both aseptic procedures and a final sterilization step, ensuring product safety and efficacy. Among its offerings is EpiFix, a semi-permeable membrane designed to act as a protective barrier, effectively treating persistent wounds such as diabetic foot ulcers, venous leg ulcers, and pressure sores. Another key product is AmnioFix, a protective, semi-permeable allograft made from dehydrated human amnion/chorion membrane, utilized to aid post-surgical recovery. EpiCord and AmnioCord, both derived from dehydrated human umbilical cord, function as allografts that foster a protective healing environment and are applied in both advanced wound care and surgical recovery contexts. AMNIOBURN is also a semi-permeable protective allograft specifically developed for managing partial and full-thickness burn injuries. Its flagship product, mdHACM, is a micronized, powdered version of AMNIOFIX. These products predominantly find use in healthcare sectors like wound management, burn treatment, surgical procedures, and non-operative sports medicine. Additionally, the company supplies allografts for dental uses to other manufacturers on an original equipment manufacturer (OEM) basis. Distribution of its products primarily occurs within the United States, facilitated by its own sales teams, independent agents, and various independent distributors. MiMedx Group, Inc.'s main office is located in Marietta, Georgia.

Market cap$704.9M
Employees808
MiMedx Group, Inc competitors & alternatives →
Orthofix Medical Inc.OFIX · Medical DevicesLewisville, United States
62% matchPublic

Orthofix Medical Inc., founded in 1980 and headquartered in Lewisville, Texas, operates as a global medical technology company focusing on devices and biologics. Its reach extends across the United States, several European nations including Italy, Germany, France, and the United Kingdom, as well as Brazil and other international markets. The company's operations are divided into two main segments: Global Spine and Global Orthopedics. Within the Global Spine division, Orthofix is responsible for the development, production, and distribution of bone growth stimulators. These devices are designed to facilitate bone fusion and serve as a therapeutic intervention for fractures located outside the spine and in the limbs. This segment also creates and commercializes a range of motion preservation and fixation implant products utilized in spinal surgical procedures. Furthermore, it supplies physicians with various tissue forms and synthetic-based regenerative biologic solutions to address a wide spectrum of spinal and orthopedic conditions. The Global Orthopedics segment concentrates on the design, development, and commercialization of specialized orthopedic products. These offerings are essential for procedures involving fracture repair, the correction of deformities, and bone reconstruction. Orthofix distributes its products to a diverse clientele, including physicians, hospitals, outpatient surgery centers, and integrated health delivery systems. This is achieved through a comprehensive sales network that includes its own sales force, independent distributors, and both employed and external sales representatives. The company, previously known as Orthofix International N.V., officially changed its name to Orthofix Medical Inc. in July 2018.

Market cap$375.1M
Employees1,616
Orthofix Medical Inc. competitors & alternatives →

Get Cerapedics's news by email

Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.

Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →

Share this card

Post the link and the card appears automatically — each network fetches the image itself.

Cerapedics — share card preview

Instagram, TikTok and Slack canvases don't expand links — download the card as a PNG and post it as an image instead.

More on Cerapedics in Xcout Intel

  • 13 named people with titles, LinkedIn and board committees
  • 5 funding rounds with the investors in each, and who they co-invest with
  • The full competitor set, tracking, exports and API access
Subscribe to Xcout Intel →